Adverse events with Zyban (buproprion)
Barbara Mintzes and associates' expressed concern last year over differences between countries in physicians' reporting of adverse reactions to prescription drugs. To illustrate, they cited significant differences in the reported rates of adverse reactions and deaths attributed to Zyban (b...
Gespeichert in:
Veröffentlicht in: | Canadian Medical Association journal (CMAJ) 2003-07, Vol.169 (2), p.103-104 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!